Table 2: Summary of results.
Active Surveillance (n = 118) |
Primary Focal Cryotherapy (n = 61) |
P-value |
|
Mean Bowel Function |
94.54 |
94.00 |
0.947 |
Mean Urinary Function |
83.76 |
86.60 |
0.278 |
Mean Sexual Function |
54.14 |
38.75 |
< 0.001 |
Mean Rate of Ejaculation* |
4.17 |
3.68 |
0.061 |
Mean Rate of Sensation of Orgasm# |
4.02 |
4.00 |
0.351 |
Mean Satisfaction with Overall Sex Life |
2.91 |
2.48 |
0.086 |
Use of Alpha Blockers |
17 (14.4%) |
26 (42.6%) |
< 0.001 |
Use of 5-α-Reductase Inhibitors |
7 (5.9%) |
23 (37.7%) |
< 0.001 |
Use of PDE-5 Inhibitors |
27 (24.3%) |
16 (30.2%) |
0.425 |
Median Time to Survey Completion |
38 months |
43 months |
0.586 |
Anxiety About Post-Treatment PSA |
0.75 |
0.68 |
0.494 |
Fear of PCa Recurrence |
8.57 |
8.54 |
0.551 |
*n = 94 for AS group, n = 44 for PFC group, #n = 95 for AS group, n = 41 for PFC group